Mostrando 10 resultados de: 11
Filtros aplicados
Publisher
Bioorganic and Medicinal Chemistry(2)
Current Medicinal Chemistry - Central Nervous System Agents(1)
Current Pharmaceutical Design(1)
European Journal of Pharmacology(1)
Expert Opinion on Investigational Drugs(1)
Área temáticas
Farmacología y terapéutica(11)
Enfermedades(4)
Fisiología humana(3)
Bioquímica(1)
Cirugía y especialidades médicas afines(1)
Origen
scopus(11)
Characterization of [<sup>3</sup>H]nisoxetine binding in rat vas deferens membranes: Modulation by sigma and PCP ligands
ArticleAbstract: Sigma (σ) and phencyclidine (PCP) receptor ligands, apart from their main effects on σ receptors andPalabras claves:Noradrenaline transporter, PCP ligands, Sigma ligands, Vas deferens, [ H]nisoxetine 3Autores:Antoni Camins, Camarasa J., Escubedo E., Gasulla D., Pallás M., Pubill D., Sureda F.X.Fuentes:scopusAssessment of the adrenergic effects of orphenadrine in rat vas deferens
ArticleAbstract: The peripheral adrenergic effects of orphenadrine, an antiparkinsonian drug, have been evaluated inPalabras claves:Autores:Antoni Camins, Camarasa J., Canudas A.M., Escubedo E., Pallás M., Pubill D., Sureda F.X.Fuentes:scopusAn overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders
ReviewAbstract: Importance of the field: The increase in life expectancy in developed countries has given rise to sePalabras claves:Alzheimer's disease, apoptosis, Neuroprotective drugs, Parkinson's DiseaseAutores:Antoni Camins, Folch J., Junyent F., Pallás M., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusAntiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusCarnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats
ArticleAbstract: The neuroprotective effect of carnosine, an endogenous antioxidant, was examined against methamphetaPalabras claves:Benzodiazepine receptor, peripheral-type, Carnosine, HSP27, Methamphetamine, [ H]GBR 12935 3, [ H]Paroxetine 3Autores:Antoni Camins, Camarasa J., Escubedo E., Pallás M., Pubill D., Sureda F.X., Verdaguer E.Fuentes:scopusEffect of PCP and sigma ligands on both noradrenaline- and electrically-induced contractions and on [<sup>3</sup>H]-noradrenaline uptake in rat vas deferens
ArticleAbstract: 1. Electrically induced contractions of the epididymal portion of rat vas deferens were potentiatedPalabras claves:Autores:Antoni Camins, Camarasa J., Canudas A.M., Escubedo E., Pallás M., Pubill D., Sureda F.X.Fuentes:scopusNew oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities
ArticleAbstract: The synthesis of several (1,2,3,5,6,7-hexahydro-1,5:3,7-dimethano-4-benzoxonin-3-yl)amines and relatPalabras claves:Amantadine, Indantadol, Memantine, NGP1-01, NMDA, Polycyclic cage compounds, TrypanosomaAutores:Antoni Camins, Camps P., Duque M.D., Kelly J.M., López-Querol M., Prathalingam S.R., Sureda F.X., Torres E., Valverde E., Vázquez S.Fuentes:scopusInhibitors of cyclin-dependent kinases: Potential drugs for the treatment of neurodegenerative disorders?
ReviewAbstract: The pharmacological treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson'Palabras claves:Autores:Allgaier C., Alvira D., Antoni Camins, Canudas A.M., Garcia De Arriba S., Pallás M., Sureda F.X., Verdaguer E.Fuentes:scopusPharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease
ReviewAbstract: To deeply understand late onset Alzheimer's disease (LOAD), it may be necessary to change the concepPalabras claves:BDNF, dendritic spines, late onset Alzheimer's disease, neuroinflammation, obesity, Type 2 Diabetes mellitusAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Casadesús G., Castro-Torres R.D., Espinosa-Jimenez T., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Sureda F.X., Verdaguer E.Fuentes:scopusSpecific binding sites for [<sup>3</sup>H]Ro 5-4864 in rat prostate and seminal vesicle
ArticleAbstract: 1. 1. The peripheral-type benzodiazepine receptor was characterized in rat prostate and seminal vesiPalabras claves:Autores:Antoni Camins, Camarasa J., Escubedo E., Sureda F.X.Fuentes:scopus